The objective of this study was to compare the sensitivity and specificity of an enzyme immunoassay employing antibodies bound to a microtiter plate (MPEIA) with those of two radioimmunoassays for screening postmortem blood from selected coroner's cases for drugs of abuse. The radioimmunoassays were a coated-tube radioimmunoassay (CTRIA) and a double antibody radioimmunoassay (DARIA). Specimens consisted of 260 postmortem blood specimens from coroner's cases. Immunoassay results (positive or negative) were compared with confirmed results on those cases by gas chromatography-mass spectrometry, alone or in combination with gas-liquid chromatography using either a nitrogen-phosphorus or flame-ionization detector. Sensitivity was calculated as the true-positive rate using chromatographic confirmation as the reference standard. Specificity was calculated as the true-negative rate. Sensitivity and specificity were calculated for 5-7 potential cutoff concentrations for the drug classes opiates, amphetamines, cocaine and metabolites, and barbiturates. For opiates, the sensitivity and specificity were 99% and 93%, respectively, for the MPEIA at a cutoff of 20-ng/mL morphine, compared with 94% and 96% for the CTRIA at a cutoff of 5-ng/mL morphine and > 99% and 96% for the DARIA at 20-ng/mL morphine. For cocaine and metabolites, the sensitivity and specificity were 96% and 93%, respectively, for the MPEIA at 50-ng/mL benzoylecgonine, compared with 93% and 96% for CTRIA at 50-ng/mL benzoylecgonine and 98% and 97% for the DARIA at 50-ng/mL benzoylecgonine. For amphetamines, the sensitivity and specificity were > 99% and 91%, respectively, for the MPEIA at 25-ng/ml. methamphetamine, compared with 93% and 86% for the CTRIA at 25-ng/ml. methamphetamine and 83% and 89% for the DARIA at 50-ng/m/methamphetamine. For barbiturates, the sensitivity and specificity were > 99% and 92%, respectively, for the MPEIA at 50-ng/ml. secobarbital, compared with 91% and 87% for the CTRIA at 500-ng/mL secobarbital and 79% and 95% for the DARIA at a cutoff of 1000-ng/mL phenobarbital.
Introduction
The microtiter plate enzyme immunoassays for drugs of abuse (MPEIA) have been used to screen antemortem blood, serum, saliva, sweat, and even hair for drugs (1) (2) (3) . The objective of this study was to evaluate the usefulness of an automated MPEIA for screening postmortem blood from autopsy cases. This was done by comparing the sensitivity and specificity of MPEIA with those of two radioimmunoassays for screening postmortem blood for drugs of abuse (4) (5) (6) (7) . The radioimmunoassays were a coatedtube radioimmunoassay (CTRIA) and a double antibody radioimmunoassay (DARIA). Specimens consisted of 260 postmortem blood specimens from coroner's cases. The samples were chosen to present difficult analytical problems as well as decomposed, thick and clotted blood specimens. The blood sample tubes were placed directly into the sample carousel of a LaboTech TM automated microplate analyzer (BioChem Immunosystems US, Inc., Allentown, PA) that pipetted the samples and reagents directly onto the coated microplate, incubated and washed the plate, added substrate, and read the resulting absorbance. Specimens were screened for opiates, amphetamines, cocaine and metabolites, and barbiturates by the automated MPEIA, the coated-tube RIA, and the double antibody RIA Immunoassay results (positive or negative) were compared with confirmed results from those cases. Gas chromatographymass spectrometry (GC-MS) analysis or gas chromatography with a nitrogen-phosphorus detector (GC-NPD) was used as the measure of presence or absence of drugs or metabolites in the drug class (8) . Sensitivity was calculated as the true-positive rate using chromatographic confirmation as the reference standard. Specificity was calculated as the true-negative rate. Sensitivity and specificity were calculated for 5-7 potential cutoff concentrations for the drug classes opiates, amphetamines, cocaine and metabolites, and barbiturates.
For the calculation of sensitivity and specificity, results were categorized into four sets. A positive immunoassay result that was confirmed by the chromatographic test was considered a true positive. A positive immunoassay result that was not confirmed was considered a false positive. A negative immunoassay result on a case for which an acid or a base screen by GC-NPD was also negative was considered a true negative. A negative immunoassay result for which the chromatography screening revealed a drug present was defined as a false negative.
The sensitivity and specificity for the microtiter plate enzyme immunoassay were determined for 5-7 possible cutoffs. The cutoff that minimized the error rate (false positives and false negatives) was chosen for the comparison with the radioimrnunoassays. Because all the immunoassays were run on the same sample population of case specimens, the results could be plotted together on ROC curves and their accuracy compared.
Methods

Microtiter plate enzyme immunoassay
The EIA reagents, Micro-Plate EIA, were obtained from STC Technologies (Bethlehem, PA). They were performed according to the manufacturer's instructions (9) , except that 25 ~L of whole blood or whole blood diluted with buffer was used instead of 25 ~L of serum. The whole-blood specimens and spiked putative cutoff standards were aliquoted into 12 x 50-ram glass tubes and assayed neat or prediluted. The neat blood samples were diluted 1:2 with phosphate buffer on the plate during the automated assay. A second set of aliquots was diluted 1:3 with phosphate buffer (Forensic Diluent, STC Technologies) in the aliquot tubes before analysis. The sample aliquots in glass tubes were loaded into the carousel of the LaboTech instrument, which pipetted 25 IJL of the samples into the antibody-coated reaction wells on the plate, added 100 I~L conjugate (drug labeled with horseradish peroxidase) to all wells, and incubated 30 min at room temperature. The plates were automatically rinsed six times with 300 IJL deionized water with aspiration between rinses. Then 100 IJL of the enzyme substrate (3,3',5,5 '-tetramethylbenzidine) was added and the absorbance read by the LaboTech instrument after a second 30-min incubation and automatic addition of 100 t~L of stopping reagents (2N sulfuric acid) to each well. Each plate held 96 wells, which required approximately 1.5 h total time between loading the aliquots and the printing out of absorbance readings. The manufacturer's serum blank, negative control, cutoff standard, and positive control were assayed at the beginning of each batch and used to calibrate the instrument. Putative whole-blood cutoff standards were assayed in duplicate with each batch and used to determine if a specimen was positive or negative for the drug.
Radioimmunoassays
The coated-tube radioimmunoassays were obtained from Diagnostic Products Corp. (Los Angeles, CA). They were performed according to manufacturer's instructions, but 100 I~L of whole blood was analyzed in place of urine and the incubation time was increased to 2 h (10).
The double antibody radioimmunoassays were obtained from Roche Diagnostics (Nutley, NJ). They were performed according to manufacturer's instructions, except that 100 I~L of whole
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GC-NPD
Promazine (1000 ng/mL) and N-propyl amphetamine (500 ng/rnL) were added to the samples as internal standards for the basic-drugs screen. The samples were adjusted to basic pH with NaOH and extracted with butyl chloride. The extracts were dried and then reconstituted in ethanol and injected into a GC equipped with an NPD or into the GC-MS.
GC-MS
An HP 5890 GC coupled with an HP 5970 or HP 5972 MS was used.
Opiates A modification of a previously published method (12) was used. The extracts were derivatized with trifluoroacetic anhydride (TFA). Deuterated morphine and codeine were used as internal standards. Calibration standards were 1000-, 100-, and 20-ng/rnL (cutoff) morphine and codeine. The ions monitored were 364 arnu and 477 amu for morphine and 395 ainu and 282 ainu for codeine. A specimen was positive if it contained morphine or codeine in a concentration greater than the 20-ng/mL cutoff.
Cocaine
A modification of a previously published method (13) was used. The extracts were derivatized with dimethyl formamide (DMF)/ dimethylformamide dipropylacetonealdehyde (DMFdiPA). Deuterated cocaine, benzoylecgonine, and cocaethylene were used as the internal standards. Calibration standards were 500-, 200-, and 20-ng/mL (cutoff) cocaine, benzoylecgonine, and cocaethylene. The ions monitored were 182 amu, 303 ainu, and 272 ainu for cocaine; 210 arnu, 331 amu, and 272 ainu, for benzoylecgonine; and 196 amu, 317 amu, and 272 ainu for cocaethylene. A sample was considered positive if it contained cocaine, benzoylecgonine, or cocaethylene greater than the 20-ng/mL cutoff.
Amphetamines
A modification of a previously published method (14) was used. The extracts were derivatized with TFA. Deuterated amphetamine and methamphetamine were used as the internal standards. Calibration standards were 1000-, 500-, and 25-ng/mL (cutoff) amphetamine and methamphetamine. The ions monitored were 140 amu and 118 arnu for amphetamine and 154 amu and 118 ainu for methamphetamine. A sample was considered positive if it contained amphetamine or methamphetamine at a concentration greater than the 25-ng/mL cutoff.
Barbiturates
A previously published method (15) was used. After solid-phase extraction, the extracts were injected into a GC with a flame ionization detector (FID) or a GC-MS for full ion scan. Various internal standards were used. Calibration concentrations were 1000-ng/mL barbiturate. Samples that contained barbiturates at levels greater than the lowest standard were considered positive.
Relative operating characteristic (ROC) analysis
The number of true positives (TP), false negatives (FN), false positives (FP), and true negatives (TN) was determined for 5-7 possible cutoff concentrations (e.g., 25-, 50-, 100-, 200-, and 500-ng/mL benzoylecgonine equivalents) by comparison of the immunoassay result to the result by GC-MS or GC-NPD for opiates, amphetamines, and cocaine. For the barbiturates, the confirmation methods were GC-FID, GC-MS full scan, or Toxilab B.
A sample was considered a true positive if both the immunoassay and the chromatographic results were in concordance, that is, both positive for cocaine (i.e., cocaine present above the putative cutoff concentration by GC-MS), or a true negative if both were negative for cocaine (i.e., no drugs found by GC-MS, GC-FID, or GC-NPD 
Specificity : TN/(TN + FP)
Because sensitivity and specificity are probabilities, the standard error (SEp) is equal to:
SEp = p~
where p is the sensitivity or specificity as a decimal number, q : 1 -p , and n is the sample size (6). Sensitivity was plotted versus 1 -specificity for the six possible cutoff concentrations to obtain ROC curves (5).
Results and Discussion
Neat versus prediluted aliquots
Predilution of the whole blood with phosphate buffer resulted in better absorbance versus concentration curves in the MPEIA with more separation between the blank whole blood and spiked whole blood cutoff standards. This, in turn, resulted in better differentiation of positive and negative responses in the specimens and fewer false positives and false negatives. For example, for the whole blood samples diluted 1:2 on the plate during the automated MPEIA assay, the diagnostic sensitivity for barbiturates was less than 86% at the best cutoff investigated (5 lag/mL phenobarbital) and for cocaine and metabolites less than 90% at a cutoff of 50-ng/mL benzoylecgonine. For this reason, only the prediluted aliquot results (1:3 dilution) are presented here. The finding that predilution of postmortem whole blood improved the results is similar to that reported by Evens (16) . Evens (16) prediluted the whole blood 1:5 and improved the perforrnance of the assay. Perrigo and Joynt (1) also remarked that dilution of the whole blood with aqueous buffer using an automated pipettor improved the performance of the microplate assay with whole blood specimens. 1 -SpeciflCily 1 -SpeKi~cily Figure 3 . P, OC graph for MPEIA on neat versus p~:liluted whole blood. The percent sensitivity (percent true positives) was plotted versus 1 -specificity (the falsepositives rate) for the microtiter plate enzyme immunoassays on neat whole blood specimens diluted on the plate 1:2 or blood samples prediluted 1:3 with phosphate buffer. A: cocaine, the ROC curve of cutoffs at 10, 25, 50,100, 200, and 500 ns/mL calculated from comparison with GC-MS (n = 204); B: methamphetamine, the ROC curve of cutoffs at 25, 50, 100, 250, and 500 ng/mL calculated from comparison with GC-MS (n = 190); C: opiates, the ROC curve of cutoffs at 1-, 2.5-, 5-, 10-, 20-, and 50-ns/mL morphine assay calculated from comparison with GC--MS (n = 218); D: morphine, the ROC curve for cutoffs at 1-, 2.5-, 5-, 10-, 20-, and 50-n~mL morphine calculated from comparison with GC-MS (n = 213); and E: barbiturates, the ROC curve of cutoffs at 10-, 25-, 50-, 100-, and 200-n~mL secobarbital (n = 130). Opiates  67  18  1  173  259  Morphine  64  9  3  183  259  Amphetamines  34  11  4  209  258  Cocaine  56  17  6  180  259  Barbiturates t  26  16  8  209  259  Barbiturates*  29  11  4 28 72 *Abbreviations: MP = MPEIA, CT = CTRIA, + = positive, (-) = negative. t MPEIA using lO0-ng/mL secobarbital versus CTRIA using 500-ng/mL secobarbital cutoff. *MPEIA using 50-ng/mL secobarbital cutoff versus CTRIA using 500-ng/mL secobarbital cutoff. * Abbreviations: MP = MPEIA, DA = DARIA, + = positive, (-) = negative. t MPEIA using 100-ng/mL secobarbital cutoff versus OARIA using 1000-ng/mL phenobarbital cutoff. * MPEIA using 50-ng/mL secobarbital cutoff versus DARIA using 1000-ng/mL phenobarbital cutoff. 
Screen MP*+/CT+ MP+/CT(-) MP(-)/CT+ MP(-)/CT(-) n
Cutoff threshold values
A blank and six cutoff concentrations spiked into blank whole blood were assayed with each run in addition to the kit calibrators and controis. The concentrations covered the dynamic range of the immunoassay except for barbiturates. The barbiturate assays were rerun on prediluted bloods using lower concentrations of secobarbital.
The optimum cutoff for the immunoassay was judged to be the analyte concentration for the cutoff calibrator that minimized the false-positive and false-negative results. Figure 1 shows the relative true-positive, false-positive, falsenegative, and true-negative results for cocaine, opiates, barbiturates, and methamphetamine for different cutoffs. The optimum cutoff values for the STC MPEIA for screening whole blood were as follows: cocaine, 50-ng/mL benzoylecgonine; morphine and opiates, 20-ng/mL morphine; methamphetamine, 25-ng/mL methamphetamine; and barbiturates, 50-ng/mL secobarbital or 5000-ng/mL phenobarbital. This low cutoff for secobarbital results from the high cross-reactivity of the immunoassay for secobarbital and the low cross-reactivity for phenobarbital and was a disadvantage for screening postmortem cases.
These cutoff or threshold values are very similar to those chosen by the UK Forensic Science Service (FSS) for forensic casework with the MPEIA (16) . The UK FSS used spiked whole blood cutoff standards containing 100-ng/mL benzoylecgonine for cocaine, 25-ng/mL morphine for opiates, 50-ng/mL amphetamine or methamphetamine for amphetamines and metabolites, and 100-ng/mL quinalbarbitone for barbiturates.
Diagnostic sensitivity and specificity
Sensitivity was calculated as the true-positive rate or the confirmation rate by chromatographic methods. Specificity was calculated as the true-negative rate. The cutoffs, sensitivity, and specificity for the three immunoassays for all five screens at their optimum cutoffs are shown in Table I . The diagnostic sensitivity and specificity values obtained in this study are conservative in that a large number of cases that had known discrepancies between the two radioimmunoassays were selected and cases that were expected to prove difficult for screening tests such as those involving decomposed bodies or multiple opiates other than morphine and codeine were included.
The ROC curves (sensitivity versus 1 -specificity) were plotted for the immunoassays to determine the relative accuracy. The ROC plots for the three immunoassays for cocaine and metabolites, opiates, barbiturates, and methamphetamine are shown in Figure 2 . The ROC plots for the MPEIA on neat versus prediluted blood samples are shown in Figure 3 .
Immunoassay agreement
The agreement between the enzyme immunoassay and the coated tube and the double antibody radioimmunoassays is shown in Tables II and IlL Overall, in 4 screens on 260 prediluted specimen aliquots, the MPEIA and the CTRIA agreed on 1258 and disagreed on 108 results. The MPEIA and the DARIA agreed on 1294 and disagreed on 72 results. All discordant cases were reviewed. The only significant finding was that at the selected cutoffs, the MPEIA detected hydrocodone (Vicodin) more often than the radioimmunoassays. Although all immunoassays gave false-positive results with badly decomposed specimens, it was noted in this study that the radioimmunoassays were more likely to give false positives with specimens from decomposed bodies. Overall, the agreement between immunoassays appeared to be determined by antibody cross-reactivity rather than antigen label. The cross-reactivity of the MPEIA assays for cocaine, opiates, barbiturates, and amphetamines is shown in Table IV (9) .
Conclusion
By employing appropriate cutoff standards using spiked postmortem blood and prediluting the whole blood specimens, the automated MPEIAs achieved sensitivities and specificities on postmortem specimens comparable with those of the radioimmunoassays. The automated MPEIA is fast and inexpensive and uses very small amounts of blood. As the MPEIA does not involve radio-labeled reagents, its use eliminates radioactive waste. The automated MPEIA is currently in routine use at one of the authors' laboratories (SDL and SLP).
